pharmaphorum Podcast
Innovative solutions to the drug pricing crisis: the pharmaphorum podcast

Innovative solutions to the drug pricing crisis: the pharmaphorum podcast

April 29, 2022

In the newest episode of the pharmaphorum podcast, Editor in Chief Jonah Comstock speaks with Dr Colin Banas, chief medical officer at DrFirst.

 

They discuss out of control drug pricing, especially in the United States, that has led to nonadherence and care rationing

Big data and how it can change the game in pharma: the pharmaphorum podcast

Big data and how it can change the game in pharma: the pharmaphorum podcast

March 23, 2022

In the latest episode of the pharmaphorum podcast, Editor in Chief Jonah Comstock speaks with Miruna Sasu, chief strategy officer of COTA and long-time pharma vet - before joining COTA last year, she headed up J&J’s Clinical Trial Feasibility and Advanced Analytics Team and led the Digital Health and Innovation Team at Bristol Myers Squibb.

The year ahead in digital health and life sciences: the pharmaphorum podcast

The year ahead in digital health and life sciences: the pharmaphorum podcast

February 10, 2022

In the latest episode of the pharmaphorum podcast, Editor in Chief Jonah Comstock speaks with Jennifer Goldsack, CEO of the Digital Medicine Society (DiMe).

Tune in to hear about the year ahead in digital health and life sciences, as well as the need for partnership and collaboration more broadly between the pharma and tech worlds. Goldsack reports on what she heard in the virtual events surrounding JP Morgan this year, and then puts some of those insights into context out of her own experience.

The evolution of clinical trials: the pharmaphorum podcast

The evolution of clinical trials: the pharmaphorum podcast

January 14, 2022

In the latest episode of the pharmaphorum podcast, Dr Paul Tunnah speaks to head of Patient Engagement at Syneos Health, Marie Emms, and Elligo Health Research vice president, strategic partnerships, Keith Fern.

Together they discuss the changing nature of clinical trials how COVID-19 impacted the sector, and the role technology is playing in supporting trial enrolment and retention.

Patient engagement processes: the pharmaphorum podcast

Patient engagement processes: the pharmaphorum podcast

December 17, 2021

This episode of the pharmaphorum podcast is the second in a limited series focused on patient engagement that’s being led clinician, consultant and patient advocate, Mark Duman.

Real-world evidence and qualitative research: the ELICIT podcast

Real-world evidence and qualitative research: the ELICIT podcast

November 25, 2021

In the first episode of the ELICIT podcast, a new series produced in partnership with Cerner Enviza, the guests discuss qualitative real-world evidence and a unique dementia project from Singapore.

Merck on trends in oncology: the pharmaphorum podcast

Merck on trends in oncology: the pharmaphorum podcast

November 12, 2021

Episode 45 of the pharmaphorum podcast heard from Dr Stuart Hill, how he’s seen the oncology landscape change and which of those he sees holding the most potential to improve patient outcomes.

Sandoz’s Pierre Bourdage on biosimilars: the pharmaphorum podcast

Sandoz’s Pierre Bourdage on biosimilars: the pharmaphorum podcast

November 5, 2021

In the latest episode of the podcast Dominic Tyer speaks with Pierre Bourdage, who’s global head of biopharmaceuticals at Sandoz about the big issues in biosimilars.

Patient engagement strategies: the pharmaphorum podcast

Patient engagement strategies: the pharmaphorum podcast

October 29, 2021

This episode of the pharmaphorum podcast is the first in an occasional series focused on patient engagement that’s being led by Mark Duman, a clinician, consultant and patient advocate.

BMS’ Catherine Owen on pharma commercialisation: the pharmaphorum podcast

BMS’ Catherine Owen on pharma commercialisation: the pharmaphorum podcast

October 15, 2021

Episode 42 of the pharmaphorum podcast heard from Catherine Owen, who’s senior vice president of major markets at Bristol Myers Squibb, about the future of pharma commercialisation and communications.

Novartis’ Amit Nastik on COVID’s supply chain impact: the pharmaphorum podcast

Novartis’ Amit Nastik on COVID’s supply chain impact: the pharmaphorum podcast

October 4, 2021

Episode 41 of the pharmaphorum podcast heard from Amit Nastik about the impact of COVID-19 on pharma supply chains and how he and his team mitigated disruption to Novartis’ own operations.

Virtual engagement and collaborations: the pharmaphorum podcast

Virtual engagement and collaborations: the pharmaphorum podcast

September 22, 2021

As the world passes the year and a half mark of the COVID-19 pandemic, the evolving experience of the ‘new normal’ environment across the healthcare sector has brought huge changes to the way pharma engages healthcare professionals.

Biotech Insight podcast: Overcoming planning challenges in oncology

Biotech Insight podcast: Overcoming planning challenges in oncology

September 8, 2021

The first episode of Kantar Health’s new Biotech Insight podcast takes aim at the planning and forecasting challenges that biotechnology companies face, with a particular focus on oncology.

Vertex senior country manager Nicola Massey: the pharmaphorum podcast

Vertex senior country manager Nicola Massey: the pharmaphorum podcast

August 23, 2021

In the latest episode of the podcast Dominic Tyer speaks with Nicola Massey, who’s Vertex’s senior country manager in the UK and Ireland.

Regenerative medicine and COVID: the pharmaphorum podcast

Regenerative medicine and COVID: the pharmaphorum podcast

August 13, 2021

In the latest episode of the podcast Dominic Tyer speaks with Dr Maria Ines ‘Mari’ Mitrani, chief science officer at the clinical-stage biopharmaceutical company Organicell Regenerative Medicine.

Podbean App

Play this podcast on Podbean App